Cart
sales@molnova.com
Puromycin dihydrochloride
CAS No. 58-58-2
Puromycin dihydrochloride( CL 13,900 | CL 16,536 | NSC 3055 | PDH )
Catalog No. M15154 CAS No. 58-58-2
Puromycin 2hydrochloride is an aminonucleoside antibiotic, which acts as a protein synthesis inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 35 | In Stock |
|
| 25MG | 63 | In Stock |
|
| 50MG | 110 | In Stock |
|
| 100MG | 177 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePuromycin dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionPuromycin 2hydrochloride is an aminonucleoside antibiotic, which acts as a protein synthesis inhibitor.
-
DescriptionPuromycin 2hydrochloride is an aminonucleoside antibiotic, which acts as a protein synthesis inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsCL 13,900 | CL 16,536 | NSC 3055 | PDH
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA synthesis| 60S ribosome
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number58-58-2
-
Formula Weight544.44
-
Molecular FormulaC22H31Cl2N7O5
-
Purity>98% (HPLC)
-
SolubilityWater: 100 mg/mL warmed (183.67 mM); DMSO: 100 mg/mL warmed (183.67 mM)
-
SMILESO=C(N[C@@H]1[C@@H](CO)O[C@@H](N2C=NC3=C(N(C)C)N=CN=C23)[C@@H]1O)[C@@H](N)CC4=CC=C(OC)C=C4.[H]Cl.[H]Cl
-
Chemical Name(2S)-2-Amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide dihydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shibouta Y, et al. Kidney Int. 1991 May;39(5):920-9.
molnova catalog
related products
-
2-(Methylamino)-1H-p...
2-(Methylamino)-1H-purin-6(7H)-one is an endogenous methylated nucleoside found in human fluids and a modified nucleoside.
-
Gemcitabine HCl
Gemcitabine HCl is a DNA synthesis inhibitor with IC50 of 50 nM, 40 nM, 18 nM and 12 nM in PANC1, MIAPaCa2, BxPC3 and Capan2 cells, respectively.
-
Deoxyshikonin
Deoxyshikonin may be a new drug candidate for wound healing and treatment of lymphatic diseases.
